Adage Capital Partners Gp, L.L.C. Pro Qr Therapeutics N.V. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,625,467 shares of PRQR stock, worth $6.02 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,625,467
Previous 3,625,467
-0.0%
Holding current value
$6.02 Million
Previous $7.18 Million
15.66%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding PRQR
# of Institutions
52Shares Held
17.4MCall Options Held
52.5KPut Options Held
11.8K-
Privium Fund Management B.V.5.34MShares$8.87 Million3.62% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.88MShares$4.79 Million0.19% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$1.69 Million2.19% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$1.5 Million0.5% of portfolio
-
Macquarie Group LTD Australia, C3620KShares$1.03 Million0.0% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $118M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...